- Home
- ZLAB vs GNW Comparison
ZLAB vs GNW Comparison
Compare ZLAB & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- GNW
- Stock Information
- Founded
- ZLAB 2013
- GNW 1871
- Country
- ZLAB China
- GNW United States
- Employees
- ZLAB N/A
- GNW N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- GNW Life Insurance
- Sector
- ZLAB Health Care
- GNW Finance
- Exchange
- ZLAB Nasdaq
- GNW Nasdaq
- Market Cap
- ZLAB 3.5B
- GNW 2.9B
- IPO Year
- ZLAB 2017
- GNW 2004
- Fundamental
- Price
- ZLAB $29.44
- GNW $7.08
- Analyst Decision
- ZLAB Buy
- GNW
- Analyst Count
- ZLAB 4
- GNW 0
- Target Price
- ZLAB $47.37
- GNW N/A
- AVG Volume (30 Days)
- ZLAB 1.4M
- GNW 7.2M
- Earning Date
- ZLAB 05-08-2025
- GNW 04-30-2025
- Dividend Yield
- ZLAB N/A
- GNW N/A
- EPS Growth
- ZLAB N/A
- GNW 141.92
- EPS
- ZLAB N/A
- GNW 0.49
- Revenue
- ZLAB $398,988,000.00
- GNW $7,217,000,000.00
- Revenue This Year
- ZLAB $44.43
- GNW N/A
- Revenue Next Year
- ZLAB $48.68
- GNW N/A
- P/E Ratio
- ZLAB N/A
- GNW $13.08
- Revenue Growth
- ZLAB 49.59
- GNW N/A
- 52 Week Low
- ZLAB $15.65
- GNW $5.87
- 52 Week High
- ZLAB $39.77
- GNW $7.90
- Technical
- Relative Strength Index (RSI)
- ZLAB 38.00
- GNW 55.10
- Support Level
- ZLAB $30.96
- GNW $6.81
- Resistance Level
- ZLAB $32.02
- GNW $6.97
- Average True Range (ATR)
- ZLAB 1.14
- GNW 0.19
- MACD
- ZLAB -0.27
- GNW 0.03
- Stochastic Oscillator
- ZLAB 4.87
- GNW 86.00
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About GNW Genworth Financial Inc
Genworth Financial is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. most of the revenue is generated by the Long-Term Care Insurance segment. The company earns most of its revenue in the United States.